 Dania Brigham
Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fontan Procedure | 4 | 2022 | 168 | 0.490 |
Why?
| | Biliary Atresia | 2 | 2021 | 160 | 0.290 |
Why?
| | Liver Transplantation | 2 | 2022 | 798 | 0.230 |
Why?
| | Academic Success | 1 | 2022 | 26 | 0.200 |
Why?
| | Airway Extubation | 1 | 2022 | 54 | 0.190 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2021 | 22 | 0.180 |
Why?
| | Anemia, Aplastic | 1 | 2021 | 35 | 0.180 |
Why?
| | Hepatitis | 1 | 2021 | 47 | 0.180 |
Why?
| | Protein-Losing Enteropathies | 1 | 2019 | 10 | 0.170 |
Why?
| | Immunoglobulin M | 1 | 2021 | 272 | 0.160 |
Why?
| | Budesonide | 1 | 2019 | 88 | 0.160 |
Why?
| | Postoperative Complications | 2 | 2020 | 2485 | 0.150 |
Why?
| | Bile Ducts | 1 | 2018 | 67 | 0.150 |
Why?
| | Glucocorticoids | 1 | 2019 | 571 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 773 | 0.120 |
Why?
| | Autoantibodies | 1 | 2021 | 1463 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2018 | 817 | 0.100 |
Why?
| | Palliative Care | 1 | 2019 | 713 | 0.100 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 740 | 0.100 |
Why?
| | Child, Preschool | 6 | 2022 | 10384 | 0.090 |
Why?
| | Cytokines | 1 | 2018 | 1983 | 0.090 |
Why?
| | Child | 7 | 2022 | 20655 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 815 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2022 | 1002 | 0.070 |
Why?
| | Retrospective Studies | 5 | 2022 | 14454 | 0.070 |
Why?
| | Adolescent | 5 | 2022 | 20179 | 0.060 |
Why?
| | Renal Replacement Therapy | 1 | 2022 | 83 | 0.050 |
Why?
| | Portoenterostomy, Hepatic | 1 | 2021 | 45 | 0.050 |
Why?
| | Horses | 1 | 2021 | 105 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2021 | 371 | 0.040 |
Why?
| | Humans | 9 | 2022 | 128417 | 0.040 |
Why?
| | Tacrolimus | 1 | 2021 | 140 | 0.040 |
Why?
| | Infant | 2 | 2022 | 8914 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2022 | 598 | 0.040 |
Why?
| | Executive Function | 1 | 2022 | 422 | 0.040 |
Why?
| | Adaptive Immunity | 1 | 2018 | 157 | 0.030 |
Why?
| | Male | 5 | 2021 | 62857 | 0.030 |
Why?
| | Length of Stay | 1 | 2022 | 1113 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2021 | 680 | 0.030 |
Why?
| | Critical Illness | 1 | 2022 | 730 | 0.030 |
Why?
| | Female | 5 | 2022 | 68153 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 507 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 345 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 803 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 429 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2021 | 10151 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 954 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2731 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1228 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1142 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1664 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2602 | 0.030 |
Why?
| | Incidence | 1 | 2019 | 2616 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4375 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 6357 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1826 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 5388 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5039 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 7036 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2018 | 3937 | 0.020 |
Why?
| | Animals | 2 | 2021 | 34479 | 0.020 |
Why?
| | Risk Factors | 1 | 2019 | 9704 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 12312 | 0.010 |
Why?
| | United States | 1 | 2019 | 13830 | 0.010 |
Why?
| | Mice | 1 | 2018 | 16602 | 0.010 |
Why?
|
|
Brigham's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|